| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 132, 604-611, Copyright © 1993 by Endocrine Society
ARTICLES |
WL Kuo, AG Montag and MR Rosner
Ben May Institute, University of Chicago, Illinois 60637.
Insulin-degrading enzyme (IDE), a cytosolic metalloendoprotease, can degrade insulin, insulin-like growth factor-II, insulin-like growth factor-I, and transforming growth factor-alpha. While IDE has been implicated in the cellular degradation of insulin, other physiological functions of this enzyme are not known. To assess the possible role of IDE in cellular growth and development, we determined the tissue and developmental distribution of the enzyme. Rat IDE cDNA fragments and antibodies directed against human IDE were used to probe IDE transcripts and proteins in rat tissues. The results demonstrate that IDE transcripts are ubiquitous in rat tissues. The level of rIDE transcripts is high in adult rat testis, tongue, and brain; moderate in kidney, prostate, heart, muscle, liver, intestine, and skin; and low in spleen, lung, thymus, and uterus. The sizes of the major transcripts of rIDE are 3.4 and 6.3 kilobases in all tissues analyzed, except testis. Surprisingly, the highest level of rIDE mRNA in the adult rat was in the testis, and the major transcripts of rIDE in this tissue were shifted in size to 3.8 and 6.7 kilobases. Immunocytochemical analysis localized the rIDE mainly in the epithelium of prostate gland and kidney, and the cytosol of liver hepatocytes. During rat development from 6-7 days of age to adulthood, rIDE mRNA levels increased in brain, testis, and tongue; decreased in muscle and skin; and did not significantly change in other tissues examined. These studies reveal regulation of IDE or IDE-related genes in rat tissues and during rat development, suggesting that this enzyme may have multiple functions relating to cellular growth and development.
This article has been cited by other articles:
![]() |
D. P. Udrisar, M. I. Wanderley, R. C. C. Porto, C. L. P. Cardoso, M. C. L. Barbosa, M. C. Camberos, and J. C. Cresto Androgen- and Estrogen-Dependent Regulation of Insulin-Degrading Enzyme in Subcellular Fractions of Rat Prostate and Uterus Experimental Biology and Medicine, July 1, 2005; 230(7): 479 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Valera Mora, A. Scarfone, M. Calvani, A. V. Greco, and G. Mingrone Insulin Clearance in Obesity J. Am. Coll. Nutr., December 1, 2003; 22(6): 487 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Morelli, R. Llovera, S. A. Gonzalez, J. L. Affranchino, F. Prelli, B. Frangione, J. Ghiso, and E. M. Castano Differential Degradation of Amyloid {beta} Genetic Variants Associated with Hereditary Dementia or Stroke by Insulin-degrading Enzyme J. Biol. Chem., June 20, 2003; 278(26): 23221 - 23226. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.C. Camberos, A.A. Pérez, D.P. Udrisar, M.I. Wanderley, and J.C. Cresto ATP Inhibits Insulin-Degrading Enzyme Activity Experimental Biology and Medicine, April 1, 2001; 226(4): 334 - 341. [Abstract] [Full Text] |
||||
![]() |
M. Bläuer, S. Husgafvel, H. Syvälä, P. Tuohimaa, and T. Ylikomi Identification of a Nuclear Localization Signal in Activin/Inhibin ßA Subunit; Intranuclear ßA in Rat Spermatogenic Cells Biol Reprod, March 1, 1999; 60(3): 588 - 593. [Abstract] [Full Text] |
||||
![]() |
W. Q. Qiu, D. M. Walsh, Z. Ye, K. Vekrellis, J. Zhang, M. B. Podlisny, M. R. Rosner, A. Safavi, L. B. Hersh, and D. J. Selkoe Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid beta -Protein by Degradation J. Biol. Chem., December 4, 1998; 273(49): 32730 - 32738. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Duckworth, R. G. Bennett, and F. G. Hamel Insulin Degradation: Progress and Potential Endocr. Rev., October 1, 1998; 19(5): 608 - 624. [Abstract] [Full Text] |
||||
![]() |
F. G. Hamel, R. G. Bennett, and W. C. Duckworth Regulation of Multicatalytic Enzyme Activity by Insulin and the Insulin-Degrading Enzyme Endocrinology, October 1, 1998; 139(10): 4061 - 4066. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Shearer, C. F. Coulter, W. C. Engeland, R. A. Roth, and M. D. Caldwell Insulin is degraded extracellularly in wounds by insulin-degrading enzyme (EC 3.4.24.56) Am J Physiol Endocrinol Metab, October 1, 1997; 273(4): E657 - E664. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Chesneau, R. K. Perlman, W. Li, G.-A. Keller, and M. R. Rosner Insulin-Degrading Enzyme Does Not Require Peroxisomal Localization for Insulin Degradation Endocrinology, August 1, 1997; 138(8): 3444 - 3451. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |